|
07/02/2009 11:42 PM
|
|
J&J takes $1bn Elan stake
|
Johnson & Johnson to buy 18 per cent of Irish-American biotech company. Deal ends months of uncertainty over group's financial stabiltity
|
|
07/01/2009 06:37 PM
|
|
Corporate fraud losses soar to £960m
|
UK corporations lost £960m to publicly reported fraud in the half year to June 30, the highest six-month total since at least 2003
|
|
06/30/2009 07:56 PM
|
|
Investors rush to buy Guilin Sanjin shares
|
China's first IPO this year receives bids for 584 times the number of shares available
|
|
06/30/2009 02:12 AM
|
|
Sanofi allays concerns on diabetes drug
|
The chief of the French pharmaceutical company takes a swipe at Diabetologia, the medical journal, for releasing studies showing a possible link between the drug Lantus and cancer
|
|
06/30/2009 12:07 AM
|
|
German group to fight thalidomider boycott call
|
Thalidomider Andreas Meyer has called for consumers not to buy medicines including painkillers made by Grunenthal, the manufacturer of thalidomide, or the luxury perfumes Tabak and 4711 made by subsidiaries of Dalli Group
|
|
06/28/2009 11:30 PM
|
|
Sanofi-Aventis seeks more generic acquisitions
|
Part of broader plans to seek full control rather than partnerships other drug makers favour
|
|
06/26/2009 11:01 PM
|
|
Consort starts on £8m restructuring
|
Drug delivery group Consort Medical is automating its US plant to help it cope with spikes in demand for its breathing tubest and face masks
|
|
06/26/2009 07:57 PM
|
|
The Golden State
|
We will not know for several years whether California's stem cell spending has paid off for its economy, but we can thank the state for its altruistic extravaganza
|
|
06/26/2009 12:08 AM
|
|
Sales of slimming pills boost Goldshield
|
The surge in popularity of slimming pills has driven sales growth at the drugmaker Goldshield Group, which this week became a takeover target for a mystery potential bidder
|
|
06/25/2009 07:55 AM
|
|
An industry to grow
|
Science: As stem cell research emerges from years of controversy with more public funding, rapid technological progess is raising medical hopes and stimulating private investment
|
|
06/24/2009 10:45 PM
|
|
Consort starts on £8m restructuring
|
The drug delivery group is automating its US plant to help it cope with increases in demand for its breathing tubes and face masks
|
|
06/24/2009 06:01 PM
|
|
New cancer treatment shows 'great promise'
|
A new way of treating cancer has shown \"great promise\" in its first clinical trial at the Royal Marsden Hospital in London
|
|
06/23/2009 03:00 AM
|
|
IDS boosted by 'remarkable' vitamin D market
|
The growing concern over vitamin D deficiency has boosted sales at Immunodiagnostic Systems, the maker of diagnostic kits, as it increased its dividend by 10%
|
|
06/21/2009 10:35 PM
|
|
Crunch time for Four Seasons
|
Some of the lenders to heavily indebted Four Seasons Healthcare Group have rejected a last ditch proposal to restructure its £1.5bn debt, turning up the heat on more senior ranking lenders to improve the offer and avoid a sale of the business
|
|
06/18/2009 11:40 PM
|
|
Creditors chase Four Seasons
|
Lenders to the care homes group are considering a last-ditch plan for a restructuring that would about halve its £1.5bn debt
|
